Daejeon, South Korea

Jin Suk Cho

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jin Suk Cho: Innovator in Pharmaceutical Processes

Introduction

Jin Suk Cho is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for synthesizing and purifying important compounds.

Latest Patents

Jin Suk Cho holds 2 patents that showcase his innovative approaches. His latest patents include a method for preparing cabazitaxel from 10-deacetylbaccatin III in high yield. This invention relates to a novel method that allows cabazitaxel to be prepared more easily and in higher purity within a shorter time compared to conventional methods. It utilizes a novel intermediate, making it suitable for industrial mass production. Another patent focuses on a process for purifying a vancomycin wet body. This process involves dissolving a wet body obtained from a microorganism-fermented solution containing vancomycin into a water-soluble solvent and carrying out reverse osmosis filtration, followed by lyophilization. This method provides high-purity vancomycin while avoiding degradation of stability during the drying step.

Career Highlights

Throughout his career, Jin Suk Cho has worked with prominent companies in the biopharmaceutical sector. He has been associated with Samyang Biopharmaceuticals Corporation and Genotech Co., Ltd., where he has contributed to various innovative projects.

Collaborations

Jin Suk Cho has collaborated with several professionals in his field, including Na Young Lee and Seong Ho Kim. These collaborations have further enhanced his research and development efforts.

Conclusion

Jin Suk Cho's contributions to pharmaceutical innovations, particularly in the synthesis and purification of critical compounds, highlight his role as a significant inventor in the industry. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…